Adam Dubow's Insider Trades & SAST Disclosures
Adam Dubow's most recent trade in Day One Biopharmaceuticals Inc was a trade of 4,646 Common Stock done at an average price of $12.0 . Disclosure was reported to the exchange on Feb. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adam Dubow.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 4,646 | 39,602 | - | 12.0 | 55,580 | Common Stock |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 40,565 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 55,313 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 40,561 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 44,248 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,962 | 35,124 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,962 | 20,740 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,750 | 12,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,750 | 36,874 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 90,000 | 90,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,687 | 35,327 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,687 | 44,252 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 3,165 | 32,162 | - | 13.2 | 41,810 | Common Stock |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,962 | 29,890 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,962 | 23,702 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,750 | 31,640 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,750 | 14,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,687 | 47,939 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,687 | 30,130 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 3,202 | 26,928 | - | 14.0 | 44,825 | Common Stock |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,962 | 24,693 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,962 | 26,664 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,750 | 26,443 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,750 | 15,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,687 | 51,626 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,687 | 24,984 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 3,253 | 21,731 | - | 16.1 | 52,304 | Common Stock |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,962 | 29,626 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,962 | 19,547 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,750 | 17,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,750 | 21,297 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,687 | 19,827 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,687 | 55,313 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 3,242 | 16,585 | - | 15.2 | 49,434 | Common Stock |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,962 | 32,588 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,962 | 14,390 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,750 | 16,140 | - | - | Common Stock | |
| Day One Biopharmaceuticals... | Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,750 | 19,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharmaceuticals... | Adam Dubow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Adam Dubow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Sale of securities on an exchange or to another person at price $ 67.90 per share. | 30 Jul 2021 | 2,466 | 13,777 (0%) | 0% | 67.9 | 167,441 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Sale of securities on an exchange or to another person at price $ 64.21 per share. | 05 May 2021 | 3,119 | 16,243 (0%) | 0% | 64.2 | 200,271 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 5,972 | 5,972 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 3,981 | 3,981 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 2,495 | 0 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 2,495 | 19,811 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 1,062 | 2,124 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 1,062 | 16,838 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 980 | 2,943 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 980 | 17,611 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.93 per share. | 10 Mar 2021 | 935 | 19,362 (0%) | 0% | 60.9 | 56,970 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2021 | 486 | 20,297 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 452 | 0 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 452 | 15,638 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 415 | 418 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 415 | 15,931 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.93 per share. | 10 Mar 2021 | 391 | 16,631 (0%) | 0% | 60.9 | 23,824 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.93 per share. | 10 Mar 2021 | 313 | 17,316 (0%) | 0% | 60.9 | 19,071 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2021 | 184 | 17,022 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.93 per share. | 10 Mar 2021 | 152 | 15,516 (0%) | 0% | 60.9 | 9,261 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.93 per share. | 10 Mar 2021 | 119 | 15,776 (0%) | 0% | 60.9 | 7,251 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2021 | 36 | 15,895 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2021 | 30 | 15,668 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2021 | 18 | 17,629 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Sale of securities on an exchange or to another person at price $ 63.39 per share. | 24 Nov 2020 | 900 | 15,186 (0%) | 0% | 63.4 | 57,051 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Adam Dubow | SVP,ChiefCompliance&EthicsOff. | Sale of securities on an exchange or to another person at price $ 61.01 per share. | 22 May 2020 | 3,200 | 16,086 (0%) | 0% | 61.0 | 195,232 | Common Stock, $0.10 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges